The global PTCA Coronary Drug Eluting Balloons Market is bound to go great guns between 2020 and 2030.
PTCA (Percutaneous Transluminal Coronary Angioplasty) comes across as a minimally-invasive procedure used for openings narrowed or blocked arteries. PTCA balloons do provide an efficient, minimally-invasive approach for broadening the narrowed coronary artery. The empty balloon is inserted into narrow arteries through a catheter. After having reached the position, inflation occurs. This, in turn, results in stenosis being displaced from vessel wall. After the procedure, the balloon gets removed. Stent placement usually follows PTCA. However, it’s not a mandate.
The PTCA coronary drug eluting balloons market is driven by the ever-growing geriatric population and adverse effects related to sedentary lifestyle, like obesity, hypertension, and vascular disorders. Plus, reclassification and technological advancements on the part of certain catheters right from class II to class III along with growing incidences of cardiovascular ailments are expected to boost the market further.
At the same time, availability on the part of alternative therapies and the complexities related to PTCA balloon catheters are likely to restrain the market. Amongst the emerging economies, the Asia-Pacific, LATAM, and MEA are expected to offer lucrative opportunities for this market.
The emergence of DEBs (drug eluting balloons) has drawn the attention of loads of healthcare providers of late, as localized drug delivery is ascertained. The basic difference between normal balloons and drug eluting balloons is that the latter make provisions for extra coating of the anti-proliferative medicine. This medicine does assert prohibition of cell division post elimination of balloon catheter.
The basic purpose of drug eluting balloons is to overpower limitations that the drug eluting stents provide. These stents are known to cause restenosis. This is also a factor promulgating the PTCA Coronary Drug Eluting Balloons Market in the years to come.
request a free sample copy
The PTCA Coronary Drug Eluting Balloons Market, by product, spans drug eluting balloon catheter, normal balloon catheter, cutting balloon catheter, and scoring balloon catheter.
By delivery platform, the market says OTW (over-the-wire) balloon catheter and rapid exchange (RX)/monorail balloon catheter. By compliance, the market consists of non-compliant and semi-compliant. By balloon material, the market says PET (polyethylene terephthalate), PE (polyethylene), and POC (polyolefin copolymer).
By region, the PTCA Coronary Drug Eluting Balloons market includes North America (Mexico, Canada, and the US), Europe (Spain, Italy, UK, France, Germany, and the Rest of Europe), the Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of the Asia-Pacific), LATAM (Brazil and the rest of LATAM), and MEA (South Africa, Saudi Arabia, and the rest of MEA).
North America and Europe have already reached the saturation stage of PTCA coronary drug eluting balloons market. The Asia-Pacific is also making greater strides. However, the future belongs to unexplored regions like LATAM and MEA. The expenditure on healthcare is growing steadily in these regions. Plus, incidences of cardiovascular diseases are growing at an exponential rate. As such, the people can actually afford the entire procedure herein. This trend is expected to bolster the PTCA coronary drug eluting balloons market going forward.
Though the ongoing pandemic has resulted in topsy-turvy situation all over, the cases where use of PTCA coronary drug eluting balloons is imperative (say – critical cases), the market hasn’t ceased to grow. These limitations have applied brakes to the market. This scenario is expected to continue atleast till mid-2021. The world is expected to get vaccinated till then. As of now, India is undergoing dry run, whereas the UK, US, and Canada are having the vaccine administered.
request a free sample copy
The key market participants are inclusive of MicroPort Scientific Corporation, THE SPECTRANETICS CORPORATION, Medtronic plc, Cardinal Health, Inc., C.R. Bard, Inc., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., Lepu Medical technology (Beijing) Co., Ltd., and Cook Medical Inc.
Table of Contents
1 PTCA Coronary Drug Eluting Balloons Market Overview
1.1 PTCA Coronary Drug Eluting Balloons Product Overview
1.2 PTCA Coronary Drug Eluting Balloons Market Segment by Type
1.2.1 DEB Balloon
1.2.2 Standard Balloon
1.3 Global PTCA Coronary Drug Eluting Balloons Market Size by Type
1.3.1 Global PTCA Coronary Drug Eluting Balloons Sales and Growth by Type
1.3.2 Global PTCA Coronary Drug Eluting Balloons Sales and Market Share by Type (2014-2019)
1.3.3 Global PTCA Coronary Drug Eluting Balloons Revenue and Market Share by Type (2014-2019)
1.3.4 Global PTCA Coronary Drug Eluting Balloons Price by Type (2014-2019)
2 Global PTCA Coronary Drug Eluting Balloons Market Competition by Company
2.1 Global PTCA Coronary Drug Eluting Balloons Sales and Market Share by Company (2014-2019)
2.2 Global PTCA Coronary Drug Eluting Balloons Revenue and Share by Company (2014-2019)
2.3 Global PTCA Coronary Drug Eluting Balloons Price by Company (2014-2019)
2.4 Global Top Players PTCA Coronary Drug Eluting Balloons Manufacturing Base Distribution, Sales Area, Product Types
2.5 PTCA Coronary Drug Eluting Balloons Market Competitive Situation and Trends
2.5.1 PTCA Coronary Drug Eluting Balloons Market Concentration Rate
2.5.2 Global PTCA Coronary Drug Eluting Balloons Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PTCA Coronary Drug Eluting Balloons Company Profiles and Sales Data
3.1 B.Braun
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 PTCA Coronary Drug Eluting Balloons Product Category, Application and Specification
3.1.3 B.Braun PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Spectranetics
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 PTCA Coronary Drug Eluting Balloons Product Category, Application and Specification
3.2.3 Spectranetics PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Concept Medical
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 PTCA Coronary Drug Eluting Balloons Product Category, Application and Specification
3.3.3 Concept Medical PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Eurocor
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 PTCA Coronary Drug Eluting Balloons Product Category, Application and Specification
3.4.3 Eurocor PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Lifetech
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 PTCA Coronary Drug Eluting Balloons Product Category, Application and Specification
3.5.3 Lifetech PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Maxcor
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 PTCA Coronary Drug Eluting Balloons Product Category, Application and Specification
3.6.3 Maxcor PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Micell
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 PTCA Coronary Drug Eluting Balloons Product Category, Application and Specification
3.7.3 Micell PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Qualimed
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 PTCA Coronary Drug Eluting Balloons Product Category, Application and Specification
3.8.3 Qualimed PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Acrostak
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 PTCA Coronary Drug Eluting Balloons Product Category, Application and Specification
3.9.3 Acrostak PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
4 PTCA Coronary Drug Eluting Balloons Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global PTCA Coronary Drug Eluting Balloons Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global PTCA Coronary Drug Eluting Balloons Sales and Revenue by Regions
4.2.1 Global PTCA Coronary Drug Eluting Balloons Sales and Market Share by Regions (2014-2019)
4.2.2 Global PTCA Coronary Drug Eluting Balloons Revenue and Market Share by Regions (2014-2019)
4.2.3 Global PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 PTCA Coronary Drug Eluting Balloons Application/End Users
5.1 PTCA Coronary Drug Eluting Balloons Segment by Application
5.1.1 Small Vessel Disease
5.1.2 Bifurcation Lesions
5.1.3 Others
5.2 Global PTCA Coronary Drug Eluting Balloons Product Segment by Application
5.2.1 Global PTCA Coronary Drug Eluting Balloons Sales by Application
5.2.2 Global PTCA Coronary Drug Eluting Balloons Sales and Market Share by Application (2014-2019)
6 Global PTCA Coronary Drug Eluting Balloons Market Forecast
6.1 Global PTCA Coronary Drug Eluting Balloons Sales, Revenue Forecast (2020-2030)
6.1.1 Global PTCA Coronary Drug Eluting Balloons Sales and Growth Rate Forecast (2020-2030)
6.1.1 Global PTCA Coronary Drug Eluting Balloons Revenue and Growth Rate Forecast (2020-2030)
6.2 Global PTCA Coronary Drug Eluting Balloons Forecast by Regions
6.2.1 North America PTCA Coronary Drug Eluting Balloons Sales and Revenue Forecast (2020-2030)
6.2.2 Europe PTCA Coronary Drug Eluting Balloons Sales and Revenue Forecast (2020-2030)
6.2.3 Asia-Pacific PTCA Coronary Drug Eluting Balloons Sales and Revenue Forecast (2020-2030)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America PTCA Coronary Drug Eluting Balloons Sales and Revenue Forecast (2020-2030)
6.2.5 Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales and Revenue Forecast (2020-2030)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 PTCA Coronary Drug Eluting Balloons Forecast by Type
6.3.1 Global PTCA Coronary Drug Eluting Balloons Sales and Revenue Forecast by Type (2020-2030)
6.3.2 DEB Balloon Gowth Forecast
6.3.3 Standard Balloon Gowth Forecast
6.4 PTCA Coronary Drug Eluting Balloons Forecast by Application
6.4.1 Global PTCA Coronary Drug Eluting Balloons Sales Forecast by Application (2020-2030)
6.4.2 Global PTCA Coronary Drug Eluting Balloons Forecast in Small Vessel Disease
6.4.3 Global PTCA Coronary Drug Eluting Balloons Forecast in Bifurcation Lesions
7 PTCA Coronary Drug Eluting Balloons Upstream Raw Materials
7.1 PTCA Coronary Drug Eluting Balloons Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 PTCA Coronary Drug Eluting Balloons Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing
